Evidence map›Paper›PMID 24060896›Full record

ArticleHypertension (Dallas, Tex. : 1979)2013

Prostaglandin E2 mediates connecting tubule glomerular feedback.

Yilin Ren, Martin A D'Ambrosio, Jeffrey L Garvin, Hong Wang, Oscar A Carretero

Open access · bronzeAbstract read
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Tubule-vascular feedback in renal autoregulation.American journal of physiology. Renal physiology · 2019
    Review
  8. Complex Role for E-Prostanoid 4 Receptors in Hypertension.Journal of the American Heart Association · 2019
    Article
  9. Article
  10. Role of connecting tubule glomerular feedback in obesity related renal damage.American journal of physiology. Renal physiology · 2018
    Article
  11. Article
  12. Article
  13. Involvement of ENaC in the development of salt-sensitive hypertension.American journal of physiology. Renal physiology · 2017
    Review
  14. PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes.Journal of the American Society of Nephrology : JASN · 2016
    Review
  15. Renal autoregulation in health and disease.Physiological reviews · 2015
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yilin RenDivision of Hypertension and Vascular Research, Department of Internal Medicine, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48202. ocarret1@hfhs.org.
Martin A D'Ambrosio
Jeffrey L Garvin
Hong Wang
Oscar A Carretero
Henry Ford Hospital · US

Funding

VASOACTIVE HORMONES IN THE REGULATION OF BLOOD PRESSUREP01HL028982 · NHLBI · HENRY FORD HOSPITAL · PI PETERSON, EDWARD LAWRENCE · 1985 to 2017
$39.8M
NHLBI NIH HHS HL28982NHLBI NIH HHS P01 HL028982
6 · The paper itself

Abstract

Connecting tubule glomerular feedback (CTGF) is a mechanism in which Na reabsorption in the connecting tubule (CNT) causes afferent arteriole (Af-Art) dilation. CTGF is mediated by eicosanoids, including prostaglandins and epoxyeicosatrienoic acids; however, their exact nature and source remain unknown. We hypothesized that during CTGF, the CNT releases prostaglandin E2, which binds its type 4 receptor (EP4) and dilates the Af-Art. Rabbit Af-Arts with the adherent CNT intact were microdissected, perfused, and preconstricted with norepinephrine. CTGF was elicited by increasing luminal NaCl in the CNT from 10 to 80 mmol/L. We induced CTGF with or without the EP4 receptor blocker ONO-AE3-208 added to the bath in the presence of the epoxyeicosatrienoic acid synthesis inhibitor MS-PPOH. ONO-AE3-208 abolished CTGF (control, 9.4 ± 0.5; MS-PPOH+ONO-AE3-208, -0.6 ± 0.2 μm; P<0.001; n=6). To confirm these results, we used a different, specific EP4 blocker, L161982 (10(-5) mol/L), that also abolished CTGF (control, 8.5 ± 0.9; MS-PPOH+L161982, 0.8 ± 0.4 μm; P<0.001; n=6). To confirm that the eicosanoids that mediate CTGF are released from the CNT rather than the Af-Art, we first disrupted the Af-Art endothelium with an antibody and complement. Endothelial disruption did not affect CTGF (7.9 ± 0.9 versus 8.6 ± 0.6 μm; P=NS; n=7). We then added arachidonic acid to the lumen of the CNT while maintaining zero NaCl in the perfusate. Arachidonic acid caused dose-dependent dilation of the attached Af-Art (from 8.6 ± 1.2 to 15.3 ± 0.7 μm; P<0.001; n=6), and this effect was blocked by ONO-AE3-208 (10(-7) mol/L). We conclude that during CTGF, the CNT releases prostaglandin E2, which acts on EP4 on the Af-Art inducing endothelium-independent dilation.

Indexed as

AmidesAnimalsArachidonic AcidDinoprostoneEndothelium, VascularFeedback, PhysiologicalKidney GlomerulusKidney TubulesMicrocirculationNaphthalenesNorepinephrinePhenylbutyratesRabbitsReceptors, Prostaglandin E, EP4 SubtypeVasodilation4-(4-cyano-2-(2-(4-fluoronaphthalen-1-yl)propionylamino)phenyl)butyric acidAmidesArachidonic AcidDinoprostoneNaphthalenesN-methylsulfonyl-6-(2-propargyloxyphenyl)hexanamideNorepinephrinePhenylbutyratesReceptors, Prostaglandin E, EP4 Subtype11,12-epoxy-5,8,14-eicosatrienoic acidarachidonic acidarteriolesendotheliummicrocirculationprostaglandin E2receptors, prostaglandin E

Identifiers

PMID24060896
PMCPMC3882006
OpenAlexW2134205277

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.